3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide has been researched along with Peripheral Nervous System Diseases in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baldari, S; De Luca, G; Di Leo, R; Girlanda, P; Mazzeo, A; Rodolico, C; Toscano, A; Vita, G | 1 |
1 other study(ies) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Peripheral Nervous System Diseases
Article | Year |
---|---|
Peripheral neuropathy as the presenting feature of multiple system atrophy.
Topics: Autonomic Nervous System; Benzamides; Contrast Media; Fatal Outcome; Humans; Male; Middle Aged; Multiple System Atrophy; Nerve Fibers, Myelinated; Peripheral Nervous System Diseases; Pyrrolidines; Tomography, Emission-Computed, Single-Photon | 2001 |